Lymphomas are among the most complex diseases to recognize and diagnose because they are pathologically complex, with features that overlap with reactive/inflammatory conditions and other nonhematologic malignancies. Dr. Paul Kurtin highlights Mayo Clinic’s highly experienced, 9-member hematopathology section focusing on lymphoma diagnosis, which diagnoses more than 3,000 lymphoma cases per year.
At least 25 different proteins have been shown to cause amyloidosis, and the underlying pathogenesis of each subtype of amyloidosis is unique. The treatment approach for each subtype of amyloidosis may be radically different. Dr. Paul Kurtin, Consultant in Hematopathology, outlines a novel diagnostic methodology developed at Mayo Clinic that can subtype amyloidosis in routine biopsy specimens with high accuracy.
Mayo Medical Laboratories offers comprehensive testing for plasma cell disorders. In this video, Dr. Kaaren Reichard, a Senior Associate Consultant in the Division of Hematopathology, provides an overview of two tests: Plasma Cell DNA Content and Proliferation and mSMART (Mayo Stratification for Myeloma And Risk-adapted Therapy).
Cancer screening tests — including the prostate-specific antigen (PSA) test to look for signs of prostate cancer — can be a good idea. Prostate cancer screening can help identify cancer early on, when treatment is most effective. And a normal PSA test, combined with a digital rectal exam, can help reassure you that it’s unlikely you have prostate cancer. But getting a PSA test for prostate cancer may not be necessary for some men, especially men 75 and older.
As you gather together with friends and family for the Thanksgiving holiday, remember to be mindful of food allergies. Feeling sick? Did you just eat too much or is it something more serious? Food allergies can cause digestive symptoms such as abdominal pain, diarrhea, nausea or vomiting. Read more for a list of tests that Mayo Medical Laboratories offers for food often found at the typical Thanksgiving feast, and a video with tips on how to avoid salmonella.
Mayo Medical Laboratories has received many questions from laboratories around the country regarding testing for fungal meningitis. The key message is that your organization should continue to use its normal approach for fungal meningitis. For your reference, we have created an informational page with up-to-date information from Mayo Clinic microbiologists and U.S. Disease Control and Prevention.
Mayo Medical Laboratories has received a number of questions from laboratories around the country in regards to testing for fungal meningitis. The key message is that your organization should continue to utilize your normal approach for fungal meningitis. For your reference, we have created an infographic with some key points from Mayo Clinic microbiologists.
Thrombotic microangiopathy is a group of disorders characterized by thrombocytopenia and microangiopathic hemolytic anemia, neurological symptoms, fever, and renal dysfunction that can cause ischemic organ injury to the brain, kidneys, heart, pancreas, liver, and lungs. Because of the variety of TMA disorders and different treatment options for each, prompt and accurate diagnosis can significantly impact a patient’s outcome.
Mayo Clinic has developed a new and more powerful test for detection and monitoring of plasma cell disorders: Plasma Cell DNA Content and Proliferation, Bone Marrow. Continue reading to learn more and to view a video discussing this new test.
The enterovirus PCR test is the recommended testing method for the detection of acute disease because it offers the advantages of rapid turnaround times, detection of circulating virus’ RNA, and improved positive predictive value (PPV).
Our comprehensive testing for celiac disease and inflammatory bowel disease evaluates patients suspected of having celiac disease, including patients with compatible symptoms, patients with atypical symptoms, and individuals at increased risk. We also offer a variety of interactive, step-by-step algorithms that provide the most appropriate selection of tests for each patient, while maintaining the highest possible sensitivity and specificity.
Over 1 million hips are implanted each year worldwide. Adverse reaction to metal debris (ARMD) occurs in a small number of patients with metal-on-metal hip replacements. Evaluation of serum chromium and cobalt concentration can help determine the degree of metal-on-metal orthopedic implant deterioration.